contact us

PLEASE DO NOT LEAVE ANY CONFIDENTIAL TREATMENT DATA, PRIVATE PATIENT DETAILS OR ANY OTHER PROTECTED HEALTH INFORMATION (PHI) ON THIS SITE. THIS IS IN ORDER TO ENSURE PRIVACY AND REGULATORY COMPLIANCE WITH APPLICABLE PRIVACY RULES AND LAWS (INCLUDING BUT NOT LIMITED TO HIPAA).
Unsubscribe From Our Mailing List

Evaluation of the H1-Coil Transcranial Magnetic Stimulation (TMS) Device – Safety and Feasibility study for Treatment of Major Depressive Episode in the elderly

Shalvata Mental Health Center, Israel

11 March 2012

The purpose of this study is to evaluate the safety and anti-depressive response of the H1 Coil TMS Device in elderly patients suffering from major depressive episode.

A randomized, sham-controlled trial is now conducted at Shalvata Mental-Health Center. Its aim is to evaluate the efficacy and safety of H1-coil Deep TMS in subjects with Major Depression, currently treated by mood stabilizers.

Contact:

Yaara Krueger
yaarakr@post.tau.ac.il

Daphna Fenchel
fenchel@post.tau.ac.il

Noah Aaron
noahaa@post.tau.ac.il

Tel: 972-9-7478644
Principal Investigator: Prof. Hilik Levkovitz